The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD. - Wikidata - awgldk - TriplyDB

The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD.

The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD.

http://www.wikidata.org/entity/Q36926305

about

Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by pro-inflammatory/cytotoxic lymphocytes.The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents.Lymphocyte senescence in COPD is associated with decreased histone deacetylase 2 expression by pro-inflammatory lymphocytes.Inflammation and immune response in COPD: where do we stand?Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes Steroid Resistant CD8+CD28null NKT-Like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease MicroRNA-134 reverses multidrug resistance in human lung adenocarcinoma cells by targeting FOXM1 Altered sputum granzyme B and granzyme B/proteinase inhibitor-9 in patients with non-eosinophilic asthma.Bronchiolitis obliterans syndrome is associated with increased p-glycoprotein expression and loss of glucocorticoid receptor from steroid resistant pro-inflammatory CD8+T cells.

P2860

Q33760782-C1C47CD3-AF01-485A-A267-6456EC14C9E7 Q34995450-5E8A02EB-DA48-4ADB-98CF-D1F5A90D49AD Q35076888-17547049-8811-49A6-B433-FFCF5E45172A Q36203564-96F61CF5-8BD4-4E75-B51F-331F6F7293B2 Q37057836-47A9A35F-C174-4572-AD33-D15888F23B8C Q37358876-264650C8-3582-43BD-BF77-65FF95E839D5 Q37512163-15724E26-B05F-4CBE-9D1A-6EB3EC3952F5 Q38814178-D2470873-E9D8-47A0-8CA2-CA0BE7521419 Q48134808-49792E53-F867-4323-9E52-576F6FAA0253 Q48202554-34ECF207-D2FE-4BB8-9EB7-F63A166BD83F

P2860

The drug efflux pump Pgp1 in pro-inflammatory lymphocytes is a target for novel treatment strategies in COPD.

http://www.wikidata.org/entity/Q36926305

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

The drug efflux pump Pgp1 in p ...... treatment strategies in COPD.

@en

type

label

The drug efflux pump Pgp1 in p ...... treatment strategies in COPD.

@en

prefLabel

The drug efflux pump Pgp1 in p ...... treatment strategies in COPD.

@en

P1433

Q36926305-53F6CD11-0D19-4598-BFAE-F9E645E4FE84

P1476

Q36926305-C3E40426-D838-4D94-BD47-2A58180BD89D

P2093

Q36926305-10A917E7-8122-4199-ACBE-74BDA50D7F9A

Q36926305-129127D3-507E-4414-A339-B5AFF98DDD02

Q36926305-846C8CE7-C548-476A-8855-4302B18977DF

Q36926305-F85F458D-B9BA-48F8-B104-6DFCE63514BC

Q36926305-FBD10BCC-89EA-4458-AA44-AD7498742446

P2860

Q36926305-12DF0BA3-592D-438F-8525-50B45FDEAA67

Q36926305-214A92C5-3CB0-4324-B9CE-F2FBD76A5DBC

Q36926305-5158319B-16E2-42BE-9FFA-71985D2640F7

Q36926305-93C24E5F-858E-45BD-91E2-F5DB0D9D3F05

Q36926305-9E913430-0B76-4B76-95D4-120EFBEFD14F

Q36926305-A1AC4D43-4381-4E23-9A58-E1F7E23963C9

Q36926305-AFEB1D4F-FDC5-4264-87B7-3A6411EA4355

Q36926305-BE0C46EF-4465-43E2-A112-6D4FCA3AB74B

Q36926305-BE148F45-81C4-422B-84E8-2AE9FA597F5F

Q36926305-D15B65DC-7211-4081-A8ED-067FA1B7B3D9

P2888

Q36926305-7E0C8747-6895-4766-823D-37955985E654

P304

Q36926305-468C4C55-59FC-4FEC-8927-A9A81E4255FF

P31

Q36926305-80A7784B-D502-4F3C-A63B-A21BD928E107

P356

Q36926305-333581B3-24AC-4BA2-80BF-B9561A520C47

P478

Q36926305-58350AE3-8D4F-4714-953A-8F2D452BF59C

P577

Q36926305-0FCD018D-DD6E-4BC0-A433-64CFFDF779E5

P5875

Q36926305-CB3DF6F7-DAC6-4FEC-A67C-884FE9450171

P6179

Q36926305-B611F742-CC79-4B53-B33D-4672F1C5DB1F

P698

Q36926305-26FA00BD-332C-4CBE-A1F5-7EE6784B0736

P932

Q36926305-E4A722FC-7B78-4B4C-8E27-43B89E633091

P356

1465-9921-14-63

P1433

Respiratory Research

P1476

The drug efflux pump Pgp1 in p ...... treatment strategies in COPD.

@en

P2093

Greg Hodge

http://www.w3.org/2001/XMLSchema#string

Hubertus Jersmann

http://www.w3.org/2001/XMLSchema#string

Mark Holmes

http://www.w3.org/2001/XMLSchema#string

Paul N Reynolds

http://www.w3.org/2001/XMLSchema#string

Sandra Hodge

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease.

Expression of a multidrug-resistance gene in human tumors and tissues

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?

Evolution of the therapeutic drug monitoring of cyclosporine.

Systemic manifestations and comorbidities of COPD.

Glucocorticoid resistance in inflammatory diseases.

Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion?

Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease.

Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway.

P2888

1465-9921-14-63

P304

63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-14-63

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237015985

http://www.w3.org/2001/XMLSchema#string

P6179

1028347898

http://www.w3.org/2001/XMLSchema#string

P698

23731729

http://www.w3.org/2001/XMLSchema#string

P932

3681551

http://www.w3.org/2001/XMLSchema#string